CTDs and lung disease Flashcards

1
Q

what 4 things are important to consider with ILD and CTDs

A
  1. is ILD part of the underlying disease or unrelated
  2. what investigations are needed
  3. is it linked to the treatment
  4. how is it going to affect the prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is UIP

A

Usual interstitial pneumonia (UIP) - a form of lung disease characterized by progressive scarring of both lungs ( fibrosis of interstitium)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

characteristics of IPF/UIP pattern disease (4)

A

> 50yro affects M>F; dry cough refactory to treatment; gradual deterioration; median survival 2-.5-3.5yrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

characteristics of NSIP pattern of disease (4)

A

median age of onset is 40-50yr; presents w SOB, cough and fatigue; cellular and fibrotic subtypes; prognosis better than IPF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

characteristics of COP pattern of disease (4)

A

mean age is 55yr; x2 as common in smokers; productive cough; good response to oral steroids (treatment needed for >6 months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

characteristics of AIP pattern of disease (3)

A

meam age is 50yro; rapid onset of symptoms with dramatic detioration; hypoxemia and resp failure occur/ARDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is another name for AIP

A

Hamman Rich syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

characteristics of LIP (lymphatic interstitial pneumonia) pattern of disease

A

poorly defined clinical characteristics; mean age 50yro; cough and SOB; strongly associated with Sjogren’s; variable response to steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

6 CTD conditions that are associated with ILD

A

RA (majority); sytemic sclerosis; SLE; dermatomyositis; Sjogren’s; mixed connective tissue disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what RA pts are more likley to get ILDs (2)

A

men; those with a high-titer RhF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what patterns are seen in RA-ILD (2)

A

UIP; NSIP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

is ILD prognosis better or worse if CTD associated

A

better

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is a strong predictor for poor prognosis

A

progressive SOB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are 3 good measures for ILD progression

A

shrinking lung volumes on CXR; extent of fibrosis on HRCT; serial FVC on lung funciton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when can ILD occur during the course of CTDs (timeline)

A

can occur up to 5 years prior to typical CTD symptoms (joint disease etc.) - must check for CTD if pt presents with ILD (esp RA and dermatomyositis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

which subtype of systemic sclerosis is more strongly associated with ILD

A

dcSSc (diffuse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what does ILD commonly coexist with in systemic sclerosis

A

pulmonary hypertension

18
Q

what disease pattern is associated with SSc-ILD

19
Q

what antibody is strongly associated with SSc-ILD development

20
Q

what is the management for SSc-ILD

A

Mgx directed at detecting ILD early; various immunosuppressive agents used (steroids, colchicine, D-pencillamine, chlorambucil) but the most effective is CYCLOPHOPHAMIDE (infusion or oral)

21
Q

in someone with lung involvement and SLE what must be rules out first

A

infection - immunosuppression leads to increased risk of infection and chronic ILD is not very commonly seen

22
Q

what lung involvement is most seen in SLE (and its histology)

A

acute lupus pnuemonitis with alveolar hemorrhage;
histology - features of interstitial pneumonitis

23
Q

management of lupus pnuemonitis

A

heavy immunosuppression and plasmapherisis (1-2mg/kg corticosteroids per day + azothioprine/cyclophophamide)

24
Q

what does dermatomyositis-ILD present as (3)

A

rapidly progressing AIP; slowly progressing UIP; COP

25
what antibody is associated with dermatomyositis-ILD
anti Jo-1 (not strongly)
26
which DM-ILD substype has a poor outcome
UIP
27
what may cause breathlessness in DM-ILD (not just lung)
ILD; secondary to pulmonary hypertension; cardiac involvment; muscle weakness
28
4 poor prognostic features for DM-ILD
older age group; short history; dysphagia; inadequate response to treatment
29
what treatment is useful for acute onset DM-ILD
corticosteroids
30
what 4 subtypes are seen in sjogren's-ILD
NSIP (most common); UIP; COP; LIP
31
treatment for sjogren's-ILD
depends on extent of disease + symptoms but usually immunosuppressants - corticosteroids + azathioprine/cyclophophamide
32
what sjogren's-ILD subtype has a worse prognosis
UIP
33
what contributes ot mortality in sjogren's-ILD
lymphoproliferative malignancy and amyloidosis
34
symptoms of MTX lung injury
cough, SOB, fever
35
what is a common side effect of Mtx and what doe lung funciton tests show
lung injury; LFTs- restricitve defect, low diffusion capacity
36
MTX lung injury CXR findings (3) and HRCT
CXR - alveolar infiltrates; reticulonodular shadowing; usually diffuse or lower lobe involvement CT - patchy ground glass shadowing
37
what is the treatment for MTX lung injury
discontinuation of therapy, corticosteroids; don't reintroduce MTX (recurrence high)
38
what is the link between anti-TNF treatment and ILD
fatal exacerbations seen in pts w pre-existing ILD when given infliximab and ertanacept
39
where are crackles likely to be heard in CTD-ILD
fine end-inpiratory crackles mainly in lung bases but may be heard in axillary areas in early disease
40
what is CTD-ILD clinical assessment based on (3)
C- clinical R - radiological P - pathological
41
features of UIP on CT
honeycombing; reticular opacities; lobular loss; lung architecture disortion; apical-basal dsitribution with apical predominance